Figure 1 | Scientific Reports

Figure 1

From: Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience

Figure 1

CONSORT diagram: HR hematological relapsed or refractory disease with morphological blast detection in BM > 5%, CT conventional (front-line) chemotherapy, CR morphological complete remission, FLAMSA fludarabine, amsacrine and cytarabine based sequential conditioning regimen, salvage CT high-dose cytarabine based salvage chemotherapy, alloHSCT allogeneic hematopoietic stem cell transplantation, MRD+ measurable residual disease, MRD− no measurable residual disease, NRM non-relapse mortality, REL relapse, OS: overall survival, AD active disease, pts patients. See also supplemental text to this figure.

Back to article page